TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY66-400	glycolysis	6.53222933261652e-05	-9.6361771813821	15	7	0.0958904109589041	73	902	5315,226,5230,3098,230,5214,2026	PKM,ALDOA,PGK1,HK1,ALDOC,PFKP,ENO2
META_ANAGLYCOLYSIS-PWY	glycolysis III (from glucose)	6.53222933261652e-05	-9.6361771813821	15	7	0.0958904109589041	73	902	5315,5230,226,3098,5214,2026,230	PKM,PGK1,ALDOA,HK1,PFKP,ENO2,ALDOC
META_ANAEROFRUCAT-PWY	homolactic fermentation	6.53222933261652e-05	-9.6361771813821	15	7	0.0958904109589041	73	902	5230,226,3098,5315,230,5214,2026	PGK1,ALDOA,HK1,PKM,ALDOC,PFKP,ENO2
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.00452441327222352	-5.39826737383431	5	3	0.0410958904109589	73	902	9945,91373,6675	GFPT2,UAP1L1,UAP1
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.00594450688190684	-5.12528769897321	36	8	0.10958904109589	73	902	2026,5214,230,226,5230,3098,5315,6392	ENO2,PFKP,ALDOC,ALDOA,PGK1,HK1,PKM,SDHD
HUMAN_PWY-5067	glycogen biosynthesis	0.0140543856632899	-4.26482078505671	7	3	0.0410958904109589	73	902	55276,2632,2997	PGM2,GBE1,GYS1
META_PWY-5661	GDP-glucose biosynthesis	0.0183815469876627	-3.99640799869422	3	2	0.0273972602739726	73	902	55276,3098	PGM2,HK1
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.0183815469876627	-3.99640799869422	3	2	0.0273972602739726	73	902	3098,55276	HK1,PGM2
META_PWY66-399	gluconeogenesis III	0.0271778856124932	-3.60535166531993	15	4	0.0547945205479452	73	902	5230,226,2026,230	PGK1,ALDOA,ENO2,ALDOC
HUMAN_PWY66-399	gluconeogenesis	0.0271778856124932	-3.60535166531993	15	4	0.0547945205479452	73	902	226,5230,230,2026	ALDOA,PGK1,ALDOC,ENO2
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.0348414756609022	-3.35694677253021	4	2	0.0273972602739726	73	902	5210,5209	PFKFB4,PFKFB3
HUMAN_PWY-5874	heme degradation	0.0348414756609022	-3.35694677253021	4	2	0.0273972602739726	73	902	3162,645	HMOX1,BLVRB
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.0348414756609022	-3.35694677253021	4	2	0.0273972602739726	73	902	2997,2632	GYS1,GBE1
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.0348414756609022	-3.35694677253021	4	2	0.0273972602739726	73	902	5210,5209	PFKFB4,PFKFB3
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	0.0348414756609022	-3.35694677253021	4	2	0.0273972602739726	73	902	230,226	ALDOC,ALDOA
HUMAN_PWY66-367	ketogenesis	0.0550528505868052	-2.89946163537742	5	2	0.0273972602739726	73	902	3155,56898	HMGCL,BDH2
HUMAN_PWY66-373	sucrose degradation	0.0783173373325536	-2.54698627862389	6	2	0.0273972602739726	73	902	230,226	ALDOC,ALDOA
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.080717054616089	-2.51680539250132	13	3	0.0410958904109589	73	902	3615,10606,5471	IMPDH2,PAICS,PPAT
HUMAN_MANNCAT-PWY	D-mannose degradation	0.0809312638581924	-2.51415507891301	1	1	0.0136986301369863	73	902	4351	MPI
HUMAN_PWY-2161B	glutamate removal from folates	0.0809312638581924	-2.51415507891301	1	1	0.0136986301369863	73	902	8836	GGH
HUMAN_BGALACT-PWY	lactose degradation III	0.0809312638581924	-2.51415507891301	1	1	0.0136986301369863	73	902	2720	GLB1
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.104022518000447	-2.2631478840426	7	2	0.0273972602739726	73	902	56548,9469	CHST7,CHST3
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.104022518000447	-2.2631478840426	7	2	0.0273972602739726	73	902	6675,91373	UAP1,UAP1L1
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.131632849861139	-2.02773867223495	8	2	0.0273972602739726	73	902	9469,56548	CHST3,CHST7
HUMAN_PWY-2201	folate transformations I	0.131632849861139	-2.02773867223495	8	2	0.0273972602739726	73	902	6472,10797	SHMT2,MTHFD2
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.136574534251691	-1.99088477490796	25	4	0.0547945205479452	73	902	79695,6482,374378,6484	GALNT12,ST3GAL1,GALNT18,ST3GAL4
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.152438453125405	-1.88099435046036	17	3	0.0410958904109589	73	902	5335,5333,5331	PLCG1,PLCD1,PLCB3
META_PWY-5340	sulfate activation for sulfonation	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	9060	PAPSS2
META_PWY-7343	UDP-glucose biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	55276	PGM2
META_PWY-4041	gamma-glutamyl cycle	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	2729	GCLC
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	10606	PAICS
HUMAN_PWY-1801	formaldehyde oxidation	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	128	ADH5
HUMAN_PWY0-662	PRPP biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	5634	PRPS2
META_PWY0-662	PRPP biosynthesis I	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	5634	PRPS2
HUMAN_PWY66-14	MAP kinase cascade	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	5604	MAP2K1
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	5471	PPAT
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	6472	SHMT2
META_PWY-5874	heme degradation	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	3162	HMOX1
HUMAN_PWY-5340	sulfate activation for sulfonation	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	9060	PAPSS2
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	6472	SHMT2
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	253430	IPMK
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	10606	PAICS
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	253430	IPMK
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.155395212510785	-1.86178364904706	2	1	0.0136986301369863	73	902	5471	PPAT
META_PWY-6569	chondroitin sulfate biosynthesis	0.17280276096726	-1.75560444492003	18	3	0.0410958904109589	73	902	22856,9469,56548	CHSY1,CHST3,CHST7
HUMAN_LIPASYN-PWY	phospholipases	0.201768028483164	-1.60063661531314	29	4	0.0547945205479452	73	902	5335,5333,201164,5331	PLCG1,PLCD1,PLD6,PLCB3
HUMAN_PWY-6309	L-kynurenine degradation	0.221526362348085	-1.50721367920611	11	2	0.0273972602739726	73	902	56267,125061	KYAT3,AFMID
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	0.221526362348085	-1.50721367920611	11	2	0.0273972602739726	73	902	55191,125061	NADSYN1,AFMID
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	1371	CPOX
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	6120	RPE
META_PWY0-1296	purine ribonucleosides degradation	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	55276	PGM2
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	253430	IPMK
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	1371	CPOX
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	55276	PGM2
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	6472	SHMT2
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	55276	PGM2
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	1159	CKMT1B
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	10135	NAMPT
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	253430	IPMK
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.223902045275704	-1.49654662064602	3	1	0.0136986301369863	73	902	253430	IPMK
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.283282618790856	-1.26131022668982	23	3	0.0410958904109589	73	902	5331,5335,5333	PLCB3,PLCG1,PLCD1
META_PWY-6158	creatine-phosphate biosynthesis	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	1159	CKMT1B
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	51004	COQ6
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	4351	MPI
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	55191	NADSYN1
HUMAN_PWY66-368	ketolysis	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	56898	BDH2
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	55191	NADSYN1
HUMAN_PWY-2161	folate polyglutamylation	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	6472	SHMT2
META_PWY66-368	ketolysis	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	56898	BDH2
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	6472	SHMT2
META_PWY-3781	aerobic respiration I (cytochrome c)	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	6392	SDHD
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.28692223514828	-1.24854405760968	4	1	0.0136986301369863	73	902	51004	COQ6
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	6482	ST3GAL1
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	1633	DCK
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	55276	PGM2
META_PWY-4081	glutathione-peroxide redox reactions	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	2878	GPX3
META_PWY-4061	glutathione-mediated detoxification I	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	56267	KYAT3
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	6472	SHMT2
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	80347	COASY
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	1633	DCK
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	80347	COASY
HUMAN_PWY-3661-1	glycine betaine degradation	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	6472	SHMT2
META_PWY-6566	chondroitin biosynthesis	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	22856	CHSY1
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.344889581289309	-1.06453096741295	5	1	0.0136986301369863	73	902	55276	PGM2
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.345976413603846	-1.06138467502302	15	2	0.0273972602739726	73	902	129607,1633	CMPK2,DCK
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.345976413603846	-1.06138467502302	15	2	0.0273972602739726	73	902	3706,253430	ITPKA,IPMK
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.345976413603846	-1.06138467502302	15	2	0.0273972602739726	73	902	3706,253430	ITPKA,IPMK
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.345976413603846	-1.06138467502302	15	2	0.0273972602739726	73	902	3706,253430	ITPKA,IPMK
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.345976413603846	-1.06138467502302	15	2	0.0273972602739726	73	902	3706,253430	ITPKA,IPMK
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.350883362098978	-1.04730141245303	37	4	0.0547945205479452	73	902	5471,205,3615,10606	PPAT,AK4,IMPDH2,PAICS
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.376412095709902	-0.977070736532453	16	2	0.0273972602739726	73	902	9469,56548	CHST3,CHST7
HUMAN_PWY-4081	glutathione redox reactions I	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	2878	GPX3
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	3615	IMPDH2
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	6120	RPE
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	3615	IMPDH2
HUMAN_PWY-5996	oleate biosynthesis	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	6319	SCD
META_PWY66-367	ketogenesis	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	3155	HMGCL
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	3615	IMPDH2
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.398204030081222	-0.920790766656841	6	1	0.0136986301369863	73	902	123099	DEGS2
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	6472	SHMT2
META_PWY-7224	purine deoxyribonucleosides salvage	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	1633	DCK
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	253430	IPMK
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	125061	AFMID
META_DETOX1-PWY-1	reactive oxygen species degradation	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	2878	GPX3
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	166929	SGMS2
META_PWY-6369	inositol pyrophosphates biosynthesis	0.447234282095455	-0.804672700653101	7	1	0.0136986301369863	73	902	253430	IPMK
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.447944954466364	-0.80308492361095	66	6	0.0821917808219178	73	902	3706,5333,5286,5335,253430,5331	ITPKA,PLCD1,PIK3C2A,PLCG1,IPMK,PLCB3
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.463878230088655	-0.768133196351774	19	2	0.0273972602739726	73	902	9951,90161	HS3ST4,HS6ST2
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.463878230088655	-0.768133196351774	19	2	0.0273972602739726	73	902	3706,253430	ITPKA,IPMK
HUMAN_PWY-4061	glutathione-mediated detoxification	0.463878230088655	-0.768133196351774	19	2	0.0273972602739726	73	902	56267,8836	KYAT3,GGH
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.463878230088655	-0.768133196351774	19	2	0.0273972602739726	73	902	1040,84803	CDS1,GPAT3
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.491463930067549	-0.710366729539486	20	2	0.0273972602739726	73	902	253430,3706	IPMK,ITPKA
HUMAN_PWY-5920	heme biosynthesis	0.49232020098658	-0.708625959164704	8	1	0.0136986301369863	73	902	1371	CPOX
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.49232020098658	-0.708625959164704	8	1	0.0136986301369863	73	902	4122	MAN2A2
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	0.49232020098658	-0.708625959164704	8	1	0.0136986301369863	73	902	3615	IMPDH2
META_LEU-DEG2-PWY	L-leucine degradation I	0.49232020098658	-0.708625959164704	8	1	0.0136986301369863	73	902	3155	HMGCL
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	0.49232020098658	-0.708625959164704	8	1	0.0136986301369863	73	902	125061	AFMID
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.49232020098658	-0.708625959164704	8	1	0.0136986301369863	73	902	1371	CPOX
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.533775039162462	-0.627780803759838	9	1	0.0136986301369863	73	902	3615	IMPDH2
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.533775039162462	-0.627780803759838	9	1	0.0136986301369863	73	902	5333	PLCD1
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	0.533775039162462	-0.627780803759838	9	1	0.0136986301369863	73	902	55191	NADSYN1
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	0.533775039162462	-0.627780803759838	9	1	0.0136986301369863	73	902	56267	KYAT3
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.533775039162462	-0.627780803759838	9	1	0.0136986301369863	73	902	8877	SPHK1
HUMAN_PWY-7205	CMP phosphorylation	0.533775039162462	-0.627780803759838	9	1	0.0136986301369863	73	902	129607	CMPK2
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	0.571887493969242	-0.558812995813092	10	1	0.0136986301369863	73	902	2878	GPX3
HUMAN_PWY-6353	purine nucleotides degradation	0.571887493969242	-0.558812995813092	10	1	0.0136986301369863	73	902	3615	IMPDH2
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.571887493969242	-0.558812995813092	10	1	0.0136986301369863	73	902	129607	CMPK2
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.571887493969242	-0.558812995813092	10	1	0.0136986301369863	73	902	1633	DCK
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.606923607131158	-0.499352349004001	11	1	0.0136986301369863	73	902	3615	IMPDH2
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.606923607131158	-0.499352349004001	11	1	0.0136986301369863	73	902	129607	CMPK2
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.606923607131158	-0.499352349004001	11	1	0.0136986301369863	73	902	1633	DCK
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.615501566458522	-0.485317788342959	25	2	0.0273972602739726	73	902	9951,90161	HS3ST4,HS6ST2
META_PWY-6857	retinol biosynthesis	0.639128519231293	-0.447649719270057	12	1	0.0136986301369863	73	902	9249	DHRS3
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.639128519231293	-0.447649719270057	12	1	0.0136986301369863	73	902	10449	ACAA2
HUMAN_LEU-DEG2-PWY	leucine degradation	0.639128519231293	-0.447649719270057	12	1	0.0136986301369863	73	902	3155	HMGCL
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.668728090127481	-0.402377743734817	13	1	0.0136986301369863	73	902	129607	CMPK2
META_PWY66-409	superpathway of purine nucleotide salvage	0.668728090127481	-0.402377743734817	13	1	0.0136986301369863	73	902	3615	IMPDH2
META_PWY-6861	the visual cycle I (vertebrates)	0.668728090127481	-0.402377743734817	13	1	0.0136986301369863	73	902	9249	DHRS3
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.668728090127481	-0.402377743734817	13	1	0.0136986301369863	73	902	5333	PLCD1
META_FAO-PWY	fatty acid beta-oxidation I	0.695930395438944	-0.362505630201947	14	1	0.0136986301369863	73	902	10449	ACAA2
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	0.695930395438944	-0.362505630201947	14	1	0.0136986301369863	73	902	3615	IMPDH2
HUMAN_FAO-PWY	fatty acid beta-oxidation	0.695930395438944	-0.362505630201947	14	1	0.0136986301369863	73	902	10449	ACAA2
HUMAN_PWY-7511	protein ubiquitylation	0.697348541355845	-0.360469933875549	29	2	0.0273972602739726	73	902	92912,55236	UBE2Q2,UBA6
META_PWY-6571	dermatan sulfate biosynthesis	0.72092710842842	-0.327217244688061	15	1	0.0136986301369863	73	902	22856	CHSY1
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.72092710842842	-0.327217244688061	15	1	0.0136986301369863	73	902	9249	DHRS3
HUMAN_PWY66-398	TCA cycle	0.743894775943478	-0.295855684334734	16	1	0.0136986301369863	73	902	6392	SDHD
META_PWY66-398	TCA cycle III (animals)	0.743894775943478	-0.295855684334734	16	1	0.0136986301369863	73	902	6392	SDHD
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.748998177612428	-0.2890187285621	32	2	0.0273972602739726	73	902	125061,55191	AFMID,NADSYN1
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.764995996437481	-0.267884678584353	17	1	0.0136986301369863	73	902	90161	HS6ST2
HUMAN_PWY-6857	retinol biosynthesis	0.764995996437481	-0.267884678584353	17	1	0.0136986301369863	73	902	9249	DHRS3
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.802186189544912	-0.220414541519991	19	1	0.0136986301369863	73	902	205	AK4
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.818539992675778	-0.200233022429017	20	1	0.0136986301369863	73	902	129607	CMPK2
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.83018248983762	-0.186109735084519	38	2	0.0273972602739726	73	902	205,3615	AK4,IMPDH2
META_PWY-6564	heparan sulfate biosynthesis	0.860013171156847	-0.150807574553203	23	1	0.0136986301369863	73	902	90161	HS6ST2
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.882311315982033	-0.125210319287154	25	1	0.0136986301369863	73	902	84803	GPAT3
META_PWY-6352	3-phosphoinositide biosynthesis	0.882311315982033	-0.125210319287154	25	1	0.0136986301369863	73	902	5286	PIK3C2A
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.90109856314908	-0.104140634294542	27	1	0.0136986301369863	73	902	5286	PIK3C2A
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-5453	methylglyoxal degradation III	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY6666-1	anandamide degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PROUT-PWY	L-proline degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-5670	epoxysqualene biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PROSYN-PWY	L-proline biosynthesis I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6620	guanine and guanosine salvage	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_SERDEG-PWY	L-serine degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-4041	gamma-glutamyl cycle	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6566	chondroitin biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5686	UMP biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_GLUDEG-I-PWY	GABA shunt	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6145	superpathway of CMP-sialic acids biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6076	vitamin D3 biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY6666-2	dopamine degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PROSYN-PWY	proline biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-5177	glutaryl-CoA degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY3O-4106	NAD salvage pathway III	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY0-1182	trehalose degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY66-397	resolvin D biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-0	putrescine degradation III	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6117	spermine and spermidine degradation I	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6181	histamine degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-7179-1	purine deoxyribonucleosides degradation II	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-5030	L-histidine degradation III	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_PWY-6181	histamine degradation	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997768	-2.23213982020187e-12	2	0	0	73	902
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5269	cardiolipin biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6377	alpha-tocopherol degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6377	alpha-tocopherol degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_GLNSYN-PWY	glutamine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6133	(S)-reticuline biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY0-522	lipoate salvage	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_ALANINE-DEG3-PWY	L-alanine degradation III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6133	(S)-reticuline biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY66-421	homocarnosine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6273	phosphatidylethanolamine biosynthesis III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5326	sulfite oxidation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY66-11	BMP Signalling Pathway	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_HISHP-PWY	L-histidine degradation VI	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6535	4-aminobutyrate degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY66-388	fatty acid alpha-oxidation III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5966	fatty acid biosynthesis initiation II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5148	acyl-CoA hydrolysis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_SERDEG-PWY	L-serine degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-40	putrescine biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-40	putrescine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6399	melatonin degradation II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5766	L-glutamate degradation X	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6173	histamine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7112	4-hydroxy-2-nonenal detoxification	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6481	L-dopachrome biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6938	NADH repair	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_P121-PWY	adenine and adenosine salvage I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7501	phosphatidylserine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-4101	sorbitol degradation I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5686	UMP biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_GLUT-REDOX-PWY	glutathione-glutaredoxin redox reactions	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_GLNSYN-PWY	L-glutamine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and transhydrogenation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6132	lanosterol biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY66-366	flavin biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6241	thyroid hormone biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5905	hypusine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_GLYCGREAT-PWY	creatine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_ARGSPECAT-PWY	spermine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY66-420	carnosine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY66-421	homocarnosine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5329	L-cysteine degradation II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY66-241	bupropion degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6619	adenine and adenosine salvage VI	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY6666-1	anandamide degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6012-1	acyl carrier protein activation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6334	L-dopa degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7506	phosphatidylserine biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-46	putrescine biosynthesis III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PROUT-PWY	proline degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6132	lanosterol biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6898	thiamin salvage III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5326	sulfite oxidation IV	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6619	adenine and adenosine salvage II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-1722	formate assimilation into 5,10-methylenetetrahydrofolate	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6502	oxidized GTP and dGTP detoxification	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6173	histamine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7344	UDP-D-galactose biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-5329	L-cysteine degradation III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY0-1305	glutamate dependent acid resistance	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7725	arachidonate biosynthesis V (8-detaturase, mammals)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6938	NADH repair	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-46	putrescine biosynthesis I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-6481	L-dopachrome biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY0-1021	L-alanine biosynthesis III	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
HUMAN_PWY66-420	carnosine biosynthesis	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6134	L-tyrosine biosynthesis IV	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-6535	4-aminobutanoate degradation I	0.999999999998736	-1.26415544698943e-12	1	0	0	73	902
META_PWY-7728	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-6100	L-carnitine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-6608	guanosine nucleotides degradation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-5453	methylglyoxal degradation III	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-5331	taurine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-382	mineralocorticoid biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_ARGININE-SYN4-PWY	L-ornithine biosynthesis II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-161	oxidative ethanol degradation III	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7177	UTP and CTP dephosphorylation II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-6609	adenine and adenosine salvage III	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7724	icosapentaenoate biosynthesis III (8-desaturase, mammals)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-2301	myo-inositol biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-7283	wybutosine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-6430	thymine degradation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-6875	retinoate biosynthesis II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7727	docosahexaenoate biosynthesis IV (4-desaturase, mammals)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-21	ethanol degradation II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-5331	taurine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-387	fatty acid alpha-oxidation II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-221	nicotine degradation V	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-3982	uracil degradation I (reductive)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-6609	adenine and adenosine salvage III	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY66-392	lipoxin biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-3982	uracil degradation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_GLUDEG-I-PWY	GABA shunt	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7049	icosapentaenoate biosynthesis II (6-desaturase, mammals)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7185	UTP and CTP dephosphorylation I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7527	L-methionine salvage cycle III	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_GLYCLEAV-PWY	glycine cleavage	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY-6100	L-carnitine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY6666-2	dopamine degradation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-301	catecholamine biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-392	lipoxin biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY-7511	protein ubiquitylation	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-162	ethanol degradation IV	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
META_PWY66-381	glucocorticoid biosynthesis	0.999999999999075	-9.25370891025068e-13	3	0	0	73	902
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-4921	protein citrullination	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY66-21	ethanol degradation II	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY66-380	estradiol biosynthesis I	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6117	spermine and spermidine degradation I	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-7592	arachidonate biosynthesis III (6-desaturase, mammals)	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-7205	CMP phosphorylation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-4261	glycerol degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-6823	molybdenum cofactor biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-5177	glutaryl-CoA degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6875	retinoate biosynthesis II	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-6313	serotonin degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-6061	bile acid biosynthesis, neutral pathway	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6517	N-acetylglucosamine degradation II	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-4984	urea cycle	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6292	cysteine biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY66-162	ethanol degradation IV	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_THIOREDOX-PWY	thioredoxin pathway	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-7434	terminal O-glycans residues modification	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
META_PWY-6608	guanosine nucleotides degradation III	1.00000000000002	1.95121628815235e-14	4	0	0	73	902
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY-5130	2-oxobutanoate degradation	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY3DJ-12	ceramide de novo biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_ILEUDEG-PWY	L-isoleucine degradation I	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY66-428	L-threonine degradation V	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-5327	superpathway of L-lysine degradation	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-7277	sphingolipid biosynthesis (mammals)	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-5130	2-oxobutanoate degradation I	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY-6074	zymosterol biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY-5143	fatty acid activation	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY66-428	threonine degradation	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
HUMAN_PWY-6313	serotonin degradation	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-5972	stearate biosynthesis I (animals and fungi)	1.00000000000082	8.19259675267519e-13	6	0	0	73	902
META_PWY-4921	protein citrullination	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-4984	urea cycle	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY66-161	oxidative ethanol degradation III	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_TYRFUMCAT-PWY	L-tyrosine degradation I	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-5667	CDP-diacylglycerol biosynthesis I	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_CITRULBIO-PWY	L-citrulline biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY-4983	citrulline-nitric oxide cycle	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY66-375	leukotriene biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY66-375	leukotriene biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY66-241	bupropion degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY66-378	androgen biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-7606	docosahexaenoate biosynthesis III (6-desaturase, mammals)	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY-5030	histidine degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-6398	melatonin degradation I	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-6111	mitochondrial L-carnitine shuttle	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-6074	zymosterol biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_VALDEG-PWY	L-valine degradation I	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-4983	L-citrulline-nitric oxide cycle	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-6402	superpathway of melatonin degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_PWY-5189	tetrapyrrole biosynthesis	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY-7726	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis (6-desaturase)	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY66-201	nicotine degradation IV	1.00000000000104	1.03610374242423e-12	5	0	0	73	902
META_PWY66-374	C20 prostanoid biosynthesis	1.00000000000145	1.45404538285761e-12	7	0	0	73	902
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000145	1.45404538285761e-12	7	0	0	73	902
HUMAN_PWY66-221	nicotine degradation III	1.00000000000145	1.45404538285761e-12	7	0	0	73	902
HUMAN_PWY66-374	C20 prostanoid biosynthesis	1.00000000000145	1.45404538285761e-12	7	0	0	73	902
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000145	1.45404538285761e-12	7	0	0	73	902
META_PWY-6872	retinoate biosynthesis I	1.00000000000145	1.45404538285761e-12	7	0	0	73	902
HUMAN_PWY-7434	terminal O-glycans residues modification	1.00000000000227	2.27221852511298e-12	8	0	0	73	902
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000227	2.27221852511298e-12	8	0	0	73	902
HUMAN_PWY-6872	retinoate biosynthesis I	1.00000000000227	2.27221852511298e-12	8	0	0	73	902
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	1.00000000000227	2.27221852511298e-12	8	0	0	73	902
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000227	2.27221852511298e-12	8	0	0	73	902
HUMAN_PWY-0	putrescine degradation III	1.00000000000227	2.27221852511298e-12	8	0	0	73	902
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	1.00000000000362	3.61676733581145e-12	9	0	0	73	902
HUMAN_PWY-7527	methionine salvage cycle III	1.00000000000362	3.61676733581145e-12	9	0	0	73	902
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000362	3.61676733581145e-12	9	0	0	73	902
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000362	3.61676733581145e-12	9	0	0	73	902
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	1.00000000000362	3.61676733581145e-12	9	0	0	73	902
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000362	3.61676733581145e-12	9	0	0	73	902
META_PWY-5004	superpathway of L-citrulline metabolism	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
HUMAN_PWY-6402	superpathway of melatonin degradation	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
META_PWY66-341	cholesterol biosynthesis I	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
HUMAN_PWY-5972	stearate biosynthesis	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
HUMAN_LIPAS-PWY	triacylglycerol degradation	1.00000000000429	4.28890728928661e-12	11	0	0	73	902
META_PWY-922	mevalonate pathway I	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_PWY-922	mevalonate pathway	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_PWY-6398	melatonin degradation I	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_PWY66-201	nicotine degradation IV	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.0000000000046	4.59977401103952e-12	10	0	0	73	902
HUMAN_VALDEG-PWY	valine degradation	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
HUMAN_PWY-6571	dermatan sulfate biosynthesis	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
HUMAN_PWY-6000	gamma-linolenate biosynthesis	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
HUMAN_ILEUDEG-PWY	isoleucine degradation	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1.00000000000597	5.96502300573734e-12	12	0	0	73	902
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
META_PWY-5328	superpathway of L-methionine salvage and degradation	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
HUMAN_PWY-5328	superpathway of methionine degradation	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
HUMAN_PWY66-341	cholesterol biosynthesis I	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	1.00000000000759	7.5948735502978e-12	13	0	0	73	902
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	1.00000000000827	8.27434050345419e-12	14	0	0	73	902
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	1.00000000000827	8.27434050345419e-12	14	0	0	73	902
META_PWY-6368	3-phosphoinositide degradation	1.00000000001229	1.22869529460357e-11	19	0	0	73	902
HUMAN_PWY-6368	3-phosphoinositide degradation	1.00000000001272	1.27183896347179e-11	20	0	0	73	902
META_PWY66-5	superpathway of cholesterol biosynthesis	1.00000000001656	1.65553227429889e-11	23	0	0	73	902
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	1.00000000001807	1.80667108188682e-11	25	0	0	73	902
